We have data on 107 companies that use SOLiD. The companies using SOLiD are most often found in United States and in the Higher Education industry. SOLiD is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SOLiD usage goes back as far as 7 years and 1 months.
|Company||Lawrence Berkeley National Laboratory|
|Company||University of Pittsburgh|
|Company||University of California-Los Angeles|
|Lawrence Berkeley National Laboratory||lbl.gov||United States||200M-1000M||1000-5000|
|University of Pittsburgh||pitt.edu||United States||10M-50M||>10000|
|University of California-Los Angeles||ucla.edu||United States||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, SOLiD has a market share of about 0.1%. Other major and competing products in this category include:
SOLiD (Sequencing by Oligonucleotide Ligation and Detection) is a next-generation DNA sequencing technology developed by Life Technologies and has been commercially available since 2006. This next generation technology generates hundreds of millions to billions of small sequence reads at one time.
Looking at SOLiD customers by industry, we find that Higher Education (34%), Biotechnology (18%), Research (12%) and Hospital & Health Care (10%) are the largest segments.
61% of SOLiD customers are in United States and 7% are in India.
Of all the customers that are using SOLiD, a majority (65%) are large (>1000 employees), 7% are small (<50 employees) and 21% are medium-sized.
Of all the customers that are using SOLiD, 29% are small (<$50M), 10% are medium-sized and 48% are large (>$1000M).